Management of Back Pain with Systemic Corticosteroids

Introduction to Corticosteroid Use

The American College of Physicians recommends that steroid packs, such as prednisone, should not be used routinely for back pain and should be limited to no more than 1-2 short courses per year due to significant risks of adverse effects with minimal evidence of benefit 1
For acute non-radicular low back pain, systemic corticosteroids show no benefit over placebo for pain or function, as found in trials comparing a single intramuscular injection or a 5-day course of systemic corticosteroids and placebo 1

Six trials consistently found minimal to no differences between systemic corticosteroids and placebo for pain relief in radicular back pain, with only slight improvement in short-term pain (mean difference of 0.56 points on a 0-10 scale) 1
Function may be slightly improved in the short term, but effects are modest, highlighting the need for alternative treatments with better benefit-risk profiles 1

Increased risk of any adverse event (49% vs. 24%) and common side effects include insomnia (26% vs. 10%), nervousness (18% vs. 8%), and increased appetite (22% vs. 10%) 1
Increased risk of glucocorticoid-induced osteoporosis, especially with cumulative doses ≥5g over 1 year, and very high fracture risk with high-dose therapy (≥30 mg daily for ≥30 days) or cumulative dose ≥5g over 1 year 2, 3

Reserve systemic corticosteroids for severe, acute radicular pain that has not responded to other treatments, and not recommended for non-radicular back pain or spinal stenosis 1
Limit to no more than 1-2 short courses per year, and for patients receiving multiple courses, consider the cumulative annual dose, which should remain below 5g per year to avoid very high fracture risk 2, 3

Assess for adverse effects from previous courses, consider bone health if multiple courses are needed, and evaluate for alternative treatments with better benefit-risk profiles 1, 2, 3
Consider calcium (1000-1200 mg) and vitamin D (600-800 IU) supplementation during treatment to minimize risks 3
NSAIDs may be more appropriate for non-radicular back pain, and for inflammatory arthritis pain, consider methotrexate or other DMARDs for steroid-sparing effects 1, 5
Physical therapy and non-pharmacological approaches should be prioritized 1